CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475461709
- Phone
- (858) 684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Peterson Caryn EVP, Regulatory Affairs | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2024-01-02 | Christian Waage EVP, Tech Ops and Admin | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2024-01-02 | Aranda Richard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +487,500 | 487,500 | ||
| 2024-01-02 | Giraudo Bryan COO/CFO | Grant or award · Stock Option (Right to Buy) | +543,750 | 543,750 | ||
| 2024-01-02 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +1,312,500 | 1,312,500 | ||
| 2023-12-04 | Smith Robert Paul JR Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +1,500,000 | 1,500,000 | ||
| 2023-11-28 | Quisel John D Director | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2023-11-20 | Aranda Richard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +162,500 | 162,500 | ||
| 2023-11-20 | Giraudo Bryan COO/CFO | Grant or award · Stock Option (Right to Buy) | +181,250 | 181,250 | ||
| 2023-11-20 | Peterson Caryn EVP, Regulatory Affairs | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-11-20 | Hasnain Faheem President & CEO | Grant or award · Stock Option (Right to Buy) | +437,500 | 437,500 | ||
| 2023-11-20 | Christian Waage EVP, Tech Ops and Admin | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2023-11-15 | Milligan Sandra Director | Purchase | +32,000 | $0.79 | $25K | 32,000 |
| 2023-11-13 | Giraudo Bryan COO/CFO | Purchase | +200,000 | $0.56 | $113K | 380,010 |
| 2023-07-24 | Giraudo Bryan COO/CFO | Grant or award | +54,020 | $1.82 | $98K | 180,010 |
| 2023-07-24 | Giraudo Bryan COO/CFO | Grant or award · Common Stock | +13,505 | $0.13 | $2K | 13,505 |
| 2023-07-24 | Hasnain Faheem President & CEO | Grant or award | +540,176 | $1.82 | $983K | 5,036,073 |
| 2023-07-24 | Hasnain Faheem President & CEO | Grant or award · Common Stock Purchase Warrants | +135,044 | $0.13 | $17K | 135,044 |
| 2023-07-24 | Christian Waage EVP, Tech Ops and Admin | Grant or award | +13,504 | $1.82 | $25K | 45,892 |
| 2023-07-24 | Christian Waage EVP, Tech Ops and Admin | Grant or award · Common Stock Purchase Warrants | +3,376 | $0.13 | $422 | 3,376 |
Page 10 of 14 · 262 trades